Download e-book for kindle: 33rd Hemophilia Symposium: Hamburg 2002 by W. Schramm, H. Krebs (auth.), Professor Dr. med. Inge

By W. Schramm, H. Krebs (auth.), Professor Dr. med. Inge Scharrer, Professor Dr. med. Wolfgang Schramm (eds.)

ISBN-10: 3540009027

ISBN-13: 9783540009023

ISBN-10: 3642182607

ISBN-13: 9783642182600

Show description

Read Online or Download 33rd Hemophilia Symposium: Hamburg 2002 PDF

Similar nonfiction_10 books

Get Transition Metal Carbyne Complexes PDF

The chemistry of transition steel carbyne complexes has turn into a hugely beautiful box prior to now 20 years. in recent times its program to elements of catalysis and metathesis has won enormous curiosity from inorganic in addition to natural chemists. furthermore, natural synthesis by way of steel carbon a number of bond reagents bargains the main refined expertise presently to be had.

Additional info for 33rd Hemophilia Symposium: Hamburg 2002

Example text

Residues 484–508 contain a major determinant of the inhibitory epitope in the A2 domain of human factor VIII. J Biol Chem 1995; 270: 14505–14509 Saenko EL, Ananyeva NM, Kouiavskaia DV, Khrenov AV, Anderson JA, Shima M, Qian J,Scott D. Haemophilia A: effects of inhibitory antibodies on factor VIII functional interactions and approaches to prevent their action. Haemophilia 2002; 8: 1-11 Fulcher CA, de Graaf Mahoney S, Roberts JR, Kasper CK, Zimmerman TS. Localization of human factor FVIII inhibitor epitopes to two polypeptide fragments.

Oppermann, Elisabeth Holfeld, Dagmar Möbius, Cottbus; Johann Böhmann, Claudia Niekrens, Delmenhorst; Joachim Mößeler, Dillingen; Wolfgang Kotte, Heiner Güldenring, Dresden; Jörg Wendisch, Dresden; Heiner Trobisch, Duisburg; U. Göbel, Lex, Düsseldorf; G. Vogel, Frau Winterstein, Erfurt; Jens Klinge, M. Girisch, Erlangen; R. Eckstein, Erlangen; Christian Klinkenstein, Frankfurt (Oder); Frau I. Scharrer, Frankfurt/Main; W. Kreuz, Klarmann, Frankfurt/Main; W. H. Sutor, Barbara Ziegler, Freiburg; R.

15 days later we documented relapse of the acquired hemophilia and bleeding episodes. The factor VIII level was 4% and factor VIII inhibitor max. 9 BU. The patient received four weekly doses of Rituximab therapy at 375 mg/m2 per week. Temporary immunosuppression was achieved with steroids (100 mg/day) and, recurrent soft tissue bleedings were treated with recombinant activated factor VII. 6 days after completion of the therapy, the factor VIII level was 73% and factor VIII inhibitor titre 0 BU.

Download PDF sample

33rd Hemophilia Symposium: Hamburg 2002 by W. Schramm, H. Krebs (auth.), Professor Dr. med. Inge Scharrer, Professor Dr. med. Wolfgang Schramm (eds.)


by Charles
4.5

Rated 4.25 of 5 – based on 8 votes